These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1417145)

  • 1. Misoprostol in the prevention of gastroduodenal damage in rheumatology.
    Ballinger AB; Kumar PJ; Scott DL
    Ann Rheum Dis; 1992 Sep; 51(9):1089-93. PubMed ID: 1417145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
    Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
    Zfass AM; McHenry L; Sanyal AJ
    Gastroenterologist; 1993 Jun; 1(2):165-9. PubMed ID: 8049889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM; Bytzer P
    Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of chronic NSAID induced upper gastrointestinal toxicity.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; 2002(3):CD002296. PubMed ID: 10908548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.
    Graham DY
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):675-81. PubMed ID: 2642452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH; Salena BJ; Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to healing and prophylaxis of nonsteroidal anti-inflammatory drug-associated ulcers.
    Yeomans ND
    Am J Med; 2001 Jan; 110(1A):24S-28S. PubMed ID: 11165992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists.
    Koch M; Capurso L; Dezi A; Ferrario F; Scarpignato C
    Dig Dis; 1995 Jan; 13 Suppl 1():62-74. PubMed ID: 7697903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
    Goldstein JL
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
    Davis R; Yarker YE; Goa KL
    Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury.
    Donnelly MT; Goddard AF; Filipowicz B; Morant SV; Shield MJ; Hawkey CJ
    Aliment Pharmacol Ther; 2000 May; 14(5):529-34. PubMed ID: 10792114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
    Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol.
    Bardhan KD; Bjarnason I; Scott DL; Griffin WM; Fenn GC; Shield MJ; Morant SV
    Br J Rheumatol; 1993 Nov; 32(11):990-5. PubMed ID: 8220939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.